SCHEMBL4460927

SCHEMBL4460927

CN1CCN(c2ccc(C(N)=O)cn2)CC1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
OPRM1 P35372 1/20 0.54
OPRK1 P41145 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.53
PARP1 P09874 1/20 0.53
UBE2T Q9NPD8 1/20 0.53
KDM4E B2RXH2 1/20 0.52
ALDH1A1 P00352 1/20 0.52
HSD17B10 Q99714 1/20 0.52
HDAC2 Q92769 3/20 0.52
HDAC3 O15379 2/20 0.52
SMO Q99835 1/20 0.52
CHEK1 O14757 1/20 0.51
HRH3 Q9Y5N1 5/20 0.51
NPC1 O15118 1/20 0.50
KMT2A Q03164 1/20 0.50
HDAC10 Q969S8 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5009801 0.98 RAB9A (0.55) RAB9AL3MBTL1OPRM1OPRK1SMN1; SMN2
SCHEMBL21776925 0.87 RAB9A (0.59) RAB9AL3MBTL1SMN1; SMN2UBE2TKDM4E
SCHEMBL1329870 0.86 RAB9A (0.58) RAB9AL3MBTL1SMN1; SMN2KDM4EALDH1A1
SCHEMBL30665072 0.86 RAB9A (0.58) RAB9AL3MBTL1SMN1; SMN2KDM4EALDH1A1
SCHEMBL6117108 0.86 RAB9A (0.58) RAB9AL3MBTL1SMN1; SMN2KDM4EALDH1A1
SCHEMBL30289763 0.85 UBE2T (0.71) OPRM1OPRK1SMN1; SMN2PARP1UBE2T
SCHEMBL29475033 0.85 UBE2T (0.71) OPRM1OPRK1SMN1; SMN2PARP1UBE2T
SCHEMBL19160081 0.84 RAB9A (0.59) RAB9AL3MBTL1SMN1; SMN2KDM4EALDH1A1
Hydrochloric Acid SCHEMBL5010433 0.84 UBE2T (0.69) OPRM1OPRK1SMN1; SMN2PARP1UBE2T
SCHEMBL29074197 0.84 UBE2T (0.69) OPRM1OPRK1SMN1; SMN2PARP1UBE2T

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101437800-A Compounds and compositions as HEDGEHOG pathway modulators IRM LLC (BM) 2009-05-20 CN claimed
WO-2018125961-A1 POLY-ADP RIBOSE POLYMERASE (PARP) INHIBITORS MITOBRIDGE, INC. (US) 2018-07-05 WO disclosed
CN-103736094-A Methods and compositions for treating leukemia NOVARTIS AG 2014-04-23 CN disclosed
CN-102695547-A Methods and compositions for treating leukemia NOVARTIS AG 2012-09-26 CN disclosed
WO-2009141386-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2009-11-26 WO disclosed
CN-101437800-A Compounds and compositions as HEDGEHOG pathway modulators IRM LLC (BM) 2009-05-20 CN disclosed
EP-1308439-B1 PROLINE DERIVATIVES AND USE THEREOF AS DRUGS MITSUBISHI TANABE PHARMA CORP (JP) 2008-10-15 EP disclosed
EP-1950199-A1 Proline derivatives and use thereof as drugs Mitsubishi Tanabe Pharma Corporation (JP) 2008-07-30 EP disclosed
EP-1289982-A1 BIOISOSTERIC BENZAMIDE DERIVATIVES AND THEIR USE AS APOB-100 SECRETION INHIBITORS GLAXO GROUP LIMITED (GB) 2003-03-12 EP disclosed
WO-2001096327-A1 BIOISOSTERIC BENZAMIDE DERIVATIVES AND THEIR USE AS APoB-100 SECRETION INHIBITORS GLAXO GROUP LIMITED (GB) 2001-12-20 WO disclosed